The Pennant Group (PNTG) Competitors

$22.64
+0.40 (+1.80%)
(As of 05/10/2024 ET)

PNTG vs. TALK, INNV, WGS, DCGO, SHCR, PIII, USPH, PRVA, LFST, and DNTH

Should you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Talkspace (TALK), InnovAge (INNV), GeneDx (WGS), DocGo (DCGO), Sharecare (SHCR), P3 Health Partners (PIII), U.S. Physical Therapy (USPH), Privia Health Group (PRVA), LifeStance Health Group (LFST), and Dianthus Therapeutics (DNTH). These companies are all part of the "medical" sector.

The Pennant Group vs.

Talkspace (NASDAQ:TALK) and The Pennant Group (NASDAQ:PNTG) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, community ranking, analyst recommendations, valuation, profitability, media sentiment, risk, dividends and earnings.

In the previous week, Talkspace had 1 more articles in the media than The Pennant Group. MarketBeat recorded 18 mentions for Talkspace and 17 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.71 beat Talkspace's score of 0.53 indicating that Talkspace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Talkspace
4 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
The Pennant Group
3 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

The Pennant Group has higher revenue and earnings than Talkspace. Talkspace is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talkspace$150.04M3.18-$19.18M-$0.12-23.41
The Pennant Group$544.89M1.25$13.38M$0.5441.93

Talkspace has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 2.01, meaning that its stock price is 101% more volatile than the S&P 500.

The Pennant Group has a net margin of 2.86% compared to The Pennant Group's net margin of -12.78%. Talkspace's return on equity of 13.42% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Talkspace-12.78% -16.06% -13.51%
The Pennant Group 2.86%13.42%3.63%

Talkspace presently has a consensus target price of $3.00, suggesting a potential upside of 6.76%. The Pennant Group has a consensus target price of $23.00, suggesting a potential upside of 1.59%. Given The Pennant Group's higher possible upside, equities research analysts clearly believe Talkspace is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Talkspace
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

57.4% of Talkspace shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 18.4% of Talkspace shares are owned by insiders. Comparatively, 5.8% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

The Pennant Group received 34 more outperform votes than Talkspace when rated by MarketBeat users. Likewise, 45.33% of users gave The Pennant Group an outperform vote while only 0.00% of users gave Talkspace an outperform vote.

CompanyUnderperformOutperform
TalkspaceOutperform Votes
No Votes
Underperform Votes
3
100.00%
The Pennant GroupOutperform Votes
34
45.33%
Underperform Votes
41
54.67%

Summary

The Pennant Group beats Talkspace on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PNTG vs. The Competition

MetricThe Pennant GroupHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$668.22M$859.58M$5.05B$7.81B
Dividend YieldN/A1.68%37.43%3.93%
P/E Ratio41.9324.72120.7114.91
Price / Sales1.252.402,422.5475.12
Price / Cash28.4220.4949.3036.42
Price / Book4.142.325.354.53
Net Income$13.38M-$15.00M$106.12M$217.43M
7 Day Performance5.79%0.31%-0.90%-0.15%
1 Month Performance11.25%2.95%-3.04%-1.64%
1 Year Performance103.78%19.65%4.20%8.89%

The Pennant Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TALK
Talkspace
0.6397 of 5 stars
$3.06
-1.0%
$3.00
-2.0%
+239.9%$516.83M$150.04M-25.50472Analyst Revision
Gap Down
INNV
InnovAge
0.7123 of 5 stars
$3.55
-4.6%
$6.50
+83.1%
N/A$482.44M$720.80M-14.202,100Short Interest ↑
Analyst Revision
News Coverage
High Trading Volume
WGS
GeneDx
1.4451 of 5 stars
$17.07
+55.2%
$18.00
+5.4%
+154.6%$444.67M$202.57M-2.291,000Gap Up
High Trading Volume
DCGO
DocGo
4.7216 of 5 stars
$3.38
-6.6%
$10.58
+213.1%
-64.9%$352.10M$624.29M48.294,164Analyst Forecast
Short Interest ↓
Analyst Revision
News Coverage
SHCR
Sharecare
1.3602 of 5 stars
$0.72
-4.0%
$1.00
+39.7%
-51.5%$256.70M$445.25M-1.933,352Earnings Report
Short Interest ↑
Gap Up
PIII
P3 Health Partners
1.6239 of 5 stars
$0.54
+15.0%
$4.75
+784.2%
-69.7%$169.70M$1.27B-0.83400Short Interest ↑
News Coverage
USPH
U.S. Physical Therapy
2.7048 of 5 stars
$101.51
-0.5%
$125.67
+23.8%
-5.9%$1.53B$604.80M75.193,899Earnings Report
Dividend Announcement
Analyst Forecast
Analyst Revision
News Coverage
PRVA
Privia Health Group
4.3724 of 5 stars
$18.40
-1.3%
$27.92
+51.7%
-35.2%$2.18B$1.66B96.851,102Analyst Forecast
News Coverage
LFST
LifeStance Health Group
1.2406 of 5 stars
$6.18
-1.3%
$8.83
+42.9%
-16.9%$2.36B$1.06B-12.129,325Earnings Report
News Coverage
DNTH
Dianthus Therapeutics
1.0196 of 5 stars
$21.35
-2.5%
$42.40
+98.6%
N/A$626.62M$2.83M0.0053Analyst Forecast
Short Interest ↑
News Coverage

Related Companies and Tools

This page (NASDAQ:PNTG) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners